New diabetes clinical trial: Study on Improving Blood Glucose Homeostasis With Dorzagliatin Tablets in the Treatment of Type 2 Diabetes Mellitus Patients With Moderate to Severe Chronic Renal Insufficiency

Published on: 2026-08-26T04:00:00Z
Conditions: Type 2 Diabetes Mellitus (T2DM); Chronic Renal Insufficiency; Chronic Kidney Disease (Stages 3b-5); Glucose Homeostasis
Interventions: Drug: Dorzagliatin; Drug: Linagliptin
Sponsors: Sun Yat-sen University
Not yet recruiting
https://ift.tt/GWUdQlf